破发股博迈科H1净利降8成 上市募12亿元华林证券保荐

Core Viewpoint - 博迈科's financial performance in the first half of 2025 shows a significant decline in revenue and profit compared to the previous year, indicating potential challenges ahead for the company [1][3]. Financial Performance Summary - In the first half of 2025, 博迈科 achieved operating revenue of 1.04 billion yuan, a decrease of 1.66% year-on-year [1][3]. - The net profit attributable to shareholders was 12.39 million yuan, down 80.42% from the previous year [1][3]. - The net profit after deducting non-recurring gains and losses was 750,000 yuan, a decline of 99.09% year-on-year [1][3]. - The net cash flow from operating activities was -27.84 million yuan, compared to 49.71 million yuan in the same period last year, reflecting a significant drop [1][3]. - As of the end of 2025, the net assets attributable to shareholders were 3.17 billion yuan, a decrease of 1.78% from the end of the previous year [3]. - Total assets were reported at 4.79 billion yuan, down 11.84% from the previous year [3]. Previous Year Comparison - In 2024, 博迈科 reported operating revenue of 2.64 billion yuan, an increase of 46.76% year-on-year [5]. - The net profit attributable to shareholders in 2024 was 100.55 million yuan, a turnaround from a loss of 75.48 million yuan in the previous year [5]. - The net profit after deducting non-recurring gains and losses was 115.39 million yuan, compared to a loss of 71.90 million yuan in 2023 [5]. - The net cash flow from operating activities in 2024 was 11.87 million yuan, a decrease of 97.69% from the previous year [5]. Dividend Distribution - 博迈科 plans to distribute a cash dividend of 2.50 yuan per 10 shares to all shareholders, with the record date set for May 22, 2025 [4].